All nine investigated neuroblastoma cell lines displayed active β-catenin, i.e. the dephosphorylated nuclear form, as well as the canonical Wnt target gene Axin2, regardless of MYCN gene amplification status [12] (Fig. 1a). The gene discussed is AXIN2; the disease is neuroblastoma.